Storytelling Intervention for Atrial Fibrillation

Recruiting in Palo Alto (17 mi)

+3 other locations

Overseen byAlok Kapoor, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Massachusetts, Worcester

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?The overall goal of this study is to evaluate the effectiveness of a previously developed storytelling intervention on anticoagulation (AC) initiation/persistence in African American and Black patients with atrial fibrillation/flutter. The investigators hope to gain knowledge that may help treat atrial fibrillation or flutter and lower stroke and adverse cardiovascular event risks for African American and Black patients by increasing the use of blood thinning medications known as anticoagulants.

Eligibility Criteria

This trial is for African American and Black patients, 18 or older with a risk of stroke who are recommended but not yet on anticoagulation therapy. It's not for those under 18, non-African Americans, pregnant women, prisoners, or individuals with certain bleeding disorders or recent brain surgery.

Inclusion Criteria

I am an African-American adult with a high stroke risk not on blood thinners, but my doctor recommends starting them.

Exclusion Criteria

You have not seen a regular doctor or heart specialist in the past year.

I am under 18, not African American or Black, and don't have a diagnosis of AF or atrial flutter.

Patient who is pregnant or a prisoner

+1 more

Participant Groups

The study tests the impact of storytelling as an intervention to encourage the use of blood thinners in African American and Black patients with atrial fibrillation/flutter to reduce their stroke risk.

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention - Patient VideosExperimental Treatment1 Intervention

Videos of African Americans currently taking anticoagulation talking about their experiences with using anticoagulation or blood thinners and successfully navigating setbacks occurring with use including bleeding, falls, strokes, and affording the medications.

Group II: Control - Informational Videos (not patients)Active Control1 Intervention

Informational videos about anticoagulation and blood thinners presented by experts or actors.

Storytelling Intervention is already approved in United States for the following indications:

🇺🇸 Approved in United States as K-Talk Intervention for: